The forecasted mortality rate for Chronic Obstructive Pulmonary Diseases (COPD) among women in the US remains relatively steady from 2024 to 2028, showing only a slight decrease. The rate, expressed in female deaths per hundred thousand, is slightly lower compared to the assumed 2023 baseline data. The year-on-year variation indicates stability, with negligible percentage changes between consecutive years. Over a five-year horizon, the compound annual growth rate (CAGR) suggests a consistent, albeit minor, decline in mortality rates.
Future trends to watch include advancements in medical treatments and interventions, potential lifestyle shifts, and changes in smoking prevalence that can further impact COPD mortality rates. Monitoring policy changes in healthcare could also be crucial for understanding demographic impacts on COPD outcomes.
